Migele^™ Gel Electrophoresis Unit works with the RESOLVE^™ hemoglobin kit to detect hemoglobinopathies in newborns and adults, including sickle cell disease and other hemoglobin variants and thalassemias. Now, laboratories around the globe can conduct these crucial, lifesaving screenings with our easy-to-use, cost-efficient, scalable solution. The unit works with a water bath and a power supply to run the IEF gel. The recirculating water bath stabilizes the temperature of the gel during the IEF process, while the programmable power supply provides high voltage to the electrophoresis unit. When the gel is positioned in the unit and an electrical current is applied to the gel, the hemoglobin variant possessing an individual isoelectric point (pI) migrates through the gel. When an individual variant’s pI equals the pH in the gel, it stops migrating and forms a discrete band. When all hemoglobin bands have been focused, the gel is fixed in trichloroacetic acid. To ensure band visibility, we recommend that newborn blood spot samples be stained with our JB-2 staining system.